{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:41:19Z","timestamp":1793418079759,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-025-03667-y","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T23:42:16Z","timestamp":1749685336000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The use of Bevacizumab in the treatment of brain arteriovenous malformations: a systematic review"],"prefix":"10.1007","volume":"48","author":[{"given":"Asfand","family":"Baig Mirza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0103-9500","authenticated-orcid":false,"given":"Feras","family":"Fayez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Al-Munaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadni","family":"Georgiannakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layla","family":"Burn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amisha","family":"Vastani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoforos","family":"Syrris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jash","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Matloob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"3667_CR1","doi-asserted-by":"publisher","unstructured":"Ascha MS, Wang JF, Kumthekar P, Sloan AE, Kruchko C, Barnholtz-Sloan JS (2019) Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases. Sci Rep Nov 9. https:\/\/doi.org\/10.1038\/s41598-019-54513-3","DOI":"10.1038\/s41598-019-54513-3"},{"key":"3667_CR2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.wneu.2011.05.056","volume":"77","author":"JK Burkhardt","year":"2012","unstructured":"Burkhardt JK, Riina H, Shin BJ (2012) Intra-arterial delivery of bevacizumab after blood-brain barrier disruption for the treatment of recurrent glioblastoma: progression-free survival and overall survival. World Neurosurg Jan 77:130\u2013134. https:\/\/doi.org\/10.1016\/j.wneu.2011.05.056","journal-title":"World Neurosurg Jan"},{"key":"3667_CR3","doi-asserted-by":"publisher","unstructured":"Castro BA, Aghi MK (2014) Bevacizumab for glioblastoma: current indications, surgical implications, and future directions. Neurosurg Focus Dec 37. https:\/\/doi.org\/10.3171\/2014.9.focus14516","DOI":"10.3171\/2014.9.focus14516"},{"key":"3667_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3171\/2020.11.JNS203298","volume":"136","author":"JS Catapano","year":"2022","unstructured":"Catapano JS, Frisoli FA, Nguyen CL (2022) Intermediate-grade brain arteriovenous malformations and the boundary of operability using the supplemented Spetzler-Martin grading system. J Neurosurg Jan 136:125\u2013133. https:\/\/doi.org\/10.3171\/2020.11.JNS203298","journal-title":"J Neurosurg Jan"},{"key":"3667_CR5","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.3171\/2010.10.JNS101042","volume":"114","author":"AJ Clark","year":"2011","unstructured":"Clark AJ, Butowski NA, Chang SM (2011) Impact of bevacizumab chemotherapy on craniotomy wound healing. Et Al 114:1609\u20131616. https:\/\/doi.org\/10.3171\/2010.10.JNS101042","journal-title":"Et Al"},{"key":"3667_CR6","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1634\/theoncologist.2009-0121","volume":"14","author":"MH Cohen","year":"2009","unstructured":"Cohen MH, Shen YL, Keegan P, Pazdur R (2009) FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme. Oncologist Nov 14:1131\u20131138. https:\/\/doi.org\/10.1634\/theoncologist.2009-0121","journal-title":"Oncologist Nov"},{"key":"3667_CR7","doi-asserted-by":"publisher","first-page":"ATP445","DOI":"10.1161\/str.48.suppl_1.tp445","volume":"48","author":"DL Cooke","year":"2017","unstructured":"Cooke DL, Kim H, Smith W, Lawton M, Clarke J, Saloner D, Ko N, Sneed P, McCulloch C, Su H (2017) Abstract TP445: bevacizumab therapy for brain arteriovenous malformations. Stroke 48:ATP445\u2013ATP445. https:\/\/doi.org\/10.1161\/str.48.suppl_1.tp445","journal-title":"Stroke"},{"key":"3667_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3171\/2014.9.PEDS14198","volume":"15","author":"SR Dashti","year":"2015","unstructured":"Dashti SR, Spalding A, Kadner RJ, Yao T, Kumar A, Sun DA, LaRocca R (2015) Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain. J Neurosurg Pediatr 15:20\u201325. https:\/\/doi.org\/10.3171\/2014.9.PEDS14198","journal-title":"J Neurosurg Pediatr"},{"key":"3667_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11060-013-1214-3","volume":"115","author":"CP Deibert","year":"2013","unstructured":"Deibert CP, Ahluwalia MS, Sheehan JP (2013) Bevacizumab for refractory adverse radiation effects after stereotactic radiosurgery. J Neurooncol Nov 115:217\u2013223. https:\/\/doi.org\/10.1007\/s11060-013-1214-3","journal-title":"J Neurooncol Nov"},{"key":"3667_CR10","doi-asserted-by":"publisher","unstructured":"Derdeyn CP, Zipfel GJ, Albuquerque FC (2017) Management of brain arteriovenous malformations: A scientific statement for healthcare professionals from the American heart association\/american stroke association. Stroke Aug 48. https:\/\/doi.org\/10.1161\/STR.0000000000000134","DOI":"10.1161\/STR.0000000000000134"},{"key":"3667_CR11","doi-asserted-by":"publisher","first-page":"e000442","DOI":"10.1161\/SVIN.122.000442","volume":"3","author":"AJ Dicpinigaitis","year":"2023","unstructured":"Dicpinigaitis AJ, Ogulnick JV, Mayer SA, Gandhi CD, Al-Mufti F (2023) Increase in ruptured cerebral arteriovenous malformations and mortality in the united states: unintended consequences of the ARUBA trial?? Stroke. Vascular Interventional Neurol 3:e000442. https:\/\/doi.org\/10.1161\/SVIN.122.000442","journal-title":"Vascular Interventional Neurol"},{"key":"3667_CR12","doi-asserted-by":"publisher","unstructured":"Drape E, Anquetil T, Larrivee B, Dubrac A (2022) Brain arteriovenous malformation in hereditary hemorrhagic telangiectasia: recent advances in cellular and molecular mechanisms. Front Hum Neurosci 16. https:\/\/doi.org\/10.3389\/fnhum.2022.1006115","DOI":"10.3389\/fnhum.2022.1006115"},{"key":"3667_CR13","doi-asserted-by":"publisher","unstructured":"Elhammady MS, Heros RC (2017) Editorial: the ARUBA study: where do we go from here? https:\/\/doi.org\/10.3171\/2015.7.JNS151408","DOI":"10.3171\/2015.7.JNS151408"},{"key":"3667_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000113733","volume":"25","author":"T Frenzel","year":"2008","unstructured":"Frenzel T, Lee CZ, Kim H (2008) Feasibility of Minocycline and Doxycycline use as potential vasculostatic therapy for brain vascular malformations: pilot study of adverse events and tolerance. Cerebrovasc Dis 25:157\u2013163. https:\/\/doi.org\/10.1159\/000113733","journal-title":"Cerebrovasc Dis"},{"key":"3667_CR15","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jval.2011.04.004","volume":"14","author":"B Goulart","year":"2011","unstructured":"Goulart B, Ramsey S (2011) A trial-based assessment of the cost-utility of bevacizumab and chemotherapy versus chemotherapy alone for advanced non-small cell lung cancer. Value Health Sep-Oct 14:836\u2013845. https:\/\/doi.org\/10.1016\/j.jval.2011.04.004","journal-title":"Value Health Sep-Oct"},{"key":"3667_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3171\/jns.2003.98.1.0003","volume":"98","author":"PP Han","year":"2003","unstructured":"Han PP, Ponce FA, Spetzler RF (2003) Intention-to-treat analysis of Spetzler-Martin grades IV and V arteriovenous malformations: natural history and treatment paradigm. J Neurosurg Jan 98:3\u20137. https:\/\/doi.org\/10.3171\/jns.2003.98.1.0003","journal-title":"J Neurosurg Jan"},{"key":"3667_CR17","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1017\/S0022215118001536","volume":"132","author":"L Harrison","year":"2018","unstructured":"Harrison L, Kundra A, Jervis P (2018) The use of thalidomide therapy for refractory epistaxis in hereditary haemorrhagic telangiectasia: systematic review. J Laryngol Otol Oct 132:866\u2013871. https:\/\/doi.org\/10.1017\/S0022215118001536","journal-title":"J Laryngol Otol Oct"},{"issue":"1","key":"3667_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2377-5-1","volume":"5","author":"T Hashimoto","year":"2005","unstructured":"Hashimoto T, Matsumoto MM, Li JF, Lawton MT, Young WL (2005) California SFBSG U (Jan 24) suppression of MMP-9 by Doxycycline in brain arteriovenous malformations. BMC Neurol 5(1):1. https:\/\/doi.org\/10.1186\/1471-2377-5-1","journal-title":"BMC Neurol"},{"key":"3667_CR19","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1161\/01.STR.0000117093.59726.F9","volume":"35","author":"AV Khaw","year":"2004","unstructured":"Khaw AV, Mohr JP, Sciacca RR (2004) Association of infratentorial brain arteriovenous malformations with haemorrhage at initial presentation. Stroke Mar 35:660\u2013663. https:\/\/doi.org\/10.1161\/01.STR.0000117093.59726.F9","journal-title":"Stroke Mar"},{"key":"3667_CR20","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000513560","volume":"13","author":"F Kwong","year":"2021","unstructured":"Kwong F, Scarpelli DB, Barajas RF, Monaco D, Tanyi JA, McClelland S, Jaboin JJ (2021) Resolution of Radiation-Induced necrosis in arteriovenous malformation with bevacizumab: A case report and review of current literature. Case Rep Neurol 13:297\u2013304. https:\/\/doi.org\/10.1159\/000513560","journal-title":"Case Rep Neurol"},{"issue":"1","key":"3667_CR21","doi-asserted-by":"publisher","first-page":"15008","DOI":"10.1038\/nrdp.2015.8","volume":"28","author":"MT Lawton","year":"2015","unstructured":"Lawton MT, Rutledge WC, Kim H (2015) Brain arteriovenous malformations. Nat Rev Dis Primers May 28(1):15008. https:\/\/doi.org\/10.1038\/nrdp.2015.8","journal-title":"Nat Rev Dis Primers May"},{"key":"3667_CR22","doi-asserted-by":"publisher","unstructured":"Leblanc GG, Golanov E, Awad IA, Young WL (2009) Biology of vascular malformations of the brain NWC. Biology of vascular malformations of the brain. Stroke Dec 40. https:\/\/doi.org\/10.1161\/STROKEAHA.109.563692","DOI":"10.1161\/STROKEAHA.109.563692"},{"key":"3667_CR23","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1161\/01.STR.0000129334.05181.b6","volume":"35","author":"CZ Lee","year":"2004","unstructured":"Lee CZ, Xu B, Hashimoto T, McCulloch CE, Yang GY, Young WL (2004) Doxycycline suppresses cerebral matrix metalloproteinase-9 and angiogenesis induced by focal hyperstimulation of vascular endothelial growth factor in a mouse model. Stroke Jul 35:1715\u20131719. https:\/\/doi.org\/10.1161\/01.STR.0000129334.05181.b6","journal-title":"Stroke Jul"},{"key":"3667_CR24","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(20)30181-2","volume":"19","author":"JP Mohr","year":"2020","unstructured":"Mohr JP, Overbey HJR, A (2020) Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial. Lancet Neurol Jul 19:573\u2013581. https:\/\/doi.org\/10.1016\/S1474-4422(20)30181-2","journal-title":"Lancet Neurol Jul"},{"key":"3667_CR25","doi-asserted-by":"publisher","first-page":"826","DOI":"10.4103\/neuroindia.NI_220_17","volume":"65","author":"KK Mukherjee","year":"2017","unstructured":"Mukherjee KK, Kumar N, Tripathi M, Oinam AS, Ahuja CK, Dhandapani S, Kapoor R, Ghoshal S, Kaur R, Bhatt S (2017) Dose fractionated gamma knife radiosurgery for large arteriovenous malformations on daily or alternate day schedule outside the linear quadratic model: proof of concept and early results. A substitute to volume fractionation. Neurol India 65:826\u2013835. https:\/\/doi.org\/10.4103\/neuroindia.NI_220_17","journal-title":"Neurol India"},{"key":"3667_CR26","doi-asserted-by":"publisher","first-page":"e000114","DOI":"10.1136\/bmjno-2020-000114","volume":"3","author":"R Muster","year":"2021","unstructured":"Muster R, Ko N, Smith W, Su H, Dickey MA, Nelson J, McCulloch CE, Sneed PK, Clarke JL, Saloner DA, Eisenmenger L, Kim H, Cooke DL (2021) Proof-of-concept single-arm trial of bevacizumab therapy for brain arteriovenous malformation. BMJ Neurol Open 3:e000114. https:\/\/doi.org\/10.1136\/bmjno-2020-000114","journal-title":"BMJ Neurol Open"},{"key":"3667_CR27","doi-asserted-by":"publisher","first-page":"448","DOI":"10.23736\/S0392-9590.23.05111-8","volume":"42","author":"L Nip","year":"2023","unstructured":"Nip L, Evans N, Bali S (2023) Early experience of thalidomide therapy for high-grade peripheral and facial arteriovenous malformations. Int Angiol Oct 42:448\u2013456. https:\/\/doi.org\/10.23736\/S0392-9590.23.05111-8","journal-title":"Int Angiol Oct"},{"issue":"3","key":"3667_CR28","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.3171\/2014.6.FOCUS14228","volume":"37","author":"MB Potts","year":"2014","unstructured":"Potts MB, Zumofen DW, Raz E, Nelson PK, Riina HA (2014) Curing arteriovenous malformations using embolization. Neurosurg Focus Sep 37(3):E19. https:\/\/doi.org\/10.3171\/2014.6.FOCUS14228","journal-title":"Neurosurg Focus Sep"},{"key":"3667_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00234-023-03258-y","volume":"66","author":"M Puthuran","year":"2024","unstructured":"Puthuran M, Gravino G, Babatola F (2024) Primary endovascular embolisation of intracranial arteriovenous malformations (AVM)-UK single centre experience. Neuroradiol Feb 66:227\u2013236. https:\/\/doi.org\/10.1007\/s00234-023-03258-y","journal-title":"Neuroradiol Feb"},{"key":"3667_CR30","doi-asserted-by":"publisher","first-page":"e942","DOI":"10.1016\/j.wneu.2017.11.143","volume":"110","author":"K Quan","year":"2018","unstructured":"Quan K, Tang X, Song J, Chen X, Tian Y, Liu P, Shi Y, Yang Z, Liu Y, Zhou F, Pan L, Zhu W (2018) Salvage therapy for brain arteriovenous malformations after failure of gamma knife stereotactic radiosurgery. World Neurosurg 110:e942\u2013e951. https:\/\/doi.org\/10.1016\/j.wneu.2017.11.143","journal-title":"World Neurosurg"},{"key":"3667_CR31","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/neuros\/nyaa192","volume":"87","author":"DMS Raper","year":"2020","unstructured":"Raper DMS, Winkler EA, Rutledge WC, Cooke DL, Abla AA (2020) An update on medications for brain arteriovenous malformations. Neurosurg Oct 87:871\u2013878. https:\/\/doi.org\/10.1093\/neuros\/nyaa192","journal-title":"Neurosurg Oct"},{"key":"3667_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10456-023-09896-3","volume":"27","author":"CT Seebauer","year":"2024","unstructured":"Seebauer CT, Wiens B, Hintschich CA (2024) Targeting the microenvironment in the treatment of arteriovenous malformations. Angiogenesis Feb 27:91\u2013103. https:\/\/doi.org\/10.1007\/s10456-023-09896-3","journal-title":"Angiogenesis Feb"},{"key":"3667_CR33","doi-asserted-by":"publisher","unstructured":"Sousa F, Cruz A, Fonte P, Pinto IM, Neves-Petersen MT, Sarmento B (2017) A new paradigm for antiangiogenic therapy through controlled release of bevacizumab from PLGA nanoparticles. Scientific Reports 2017;7(1):3736. https:\/\/doi.org\/10.1038\/s41598-017-03959-4","DOI":"10.1038\/s41598-017-03959-4"},{"key":"3667_CR34","doi-asserted-by":"publisher","first-page":"700","DOI":"10.2967\/jnumed.116.187047","volume":"58","author":"C Stegmayr","year":"2017","unstructured":"Stegmayr C, Oliveira D, Niemietz N, Willuweit A, Lohmann P, Galldiks N, Shah NJ, Ermert J, Langen K-J (2017) Influence of bevacizumab on Blood\u2013Brain barrier permeability and O-(2-18F-Fluoroethyl)-l-Tyrosine uptake in rat gliomas. J Nucl Med 58:700\u2013705. https:\/\/doi.org\/10.2967\/jnumed.116.187047","journal-title":"J Nucl Med"},{"key":"3667_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/WNO.0000000000000425","volume":"36","author":"AR Sweeney","year":"2016","unstructured":"Sweeney AR, Chappell M, Khorsand DA, Jian-Amadi A, Francis CE (2016) Intralesional injection of bevacizumab for the treatment of an apical orbital cavernous venous malformation. J Neuroophthalmol 36:389\u2013392. https:\/\/doi.org\/10.1097\/WNO.0000000000000425","journal-title":"J Neuroophthalmol"},{"key":"3667_CR36","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.4103\/0028-3886.271242","volume":"67","author":"M Tripathi","year":"2019","unstructured":"Tripathi M, Ahuja CK, Mukherjee KK, Kumar N, Dhandapani S, Dutta P, Kaur R, Rekhapalli R, Batish A, Gurnani J, Kamboj P, Agrahari A, Kataria K (2019) The safety and efficacy of bevacizumab for Radiosurgery - Induced Steroid - Resistant brain edema; not the last part in the ship of Theseus. Neurol India 67:1292\u20131302. https:\/\/doi.org\/10.4103\/0028-3886.271242","journal-title":"Neurol India"},{"key":"3667_CR37","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s00701-016-2874-5","volume":"158","author":"RC Turner","year":"2016","unstructured":"Turner RC, Lucke-Wold BP, Josiah D, Gonzalez J, Schmidt M, Tarabishy AR, Bhatia S (2016) Stereotactic radiosurgery planning based on time-resolved CTA for arteriovenous malformation: a case report and review of the literature. Acta Neurochir (Wien) 158:1555\u20131562. https:\/\/doi.org\/10.1007\/s00701-016-2874-5","journal-title":"Acta Neurochir (Wien)"},{"key":"3667_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/02688697.2020.1742294","volume":"35","author":"E Uysal","year":"2021","unstructured":"Uysal E, Ba\u015fkurt O, Avc\u0131 \u0130, Peker HO, \u00c7elik SE (2021) Late recovery of stereotactic radiosurgery induced perilesional oedema of an arteriovenous malformation after bevacizumab treatment. Br J Neurosurg 35:22\u201326. https:\/\/doi.org\/10.1080\/02688697.2020.1742294","journal-title":"Br J Neurosurg"},{"key":"3667_CR39","doi-asserted-by":"publisher","unstructured":"Vernimmen FJAI (2014) Vascular endothelial growth factor blockade: A potential new therapy in the management of cerebral arteriovenous malformations. Journal of Medical Hypotheses and Ideas 2014;8(2):57\u201361. https:\/\/doi.org\/10.1016\/j.jmhi.2013.10.001","DOI":"10.1016\/j.jmhi.2013.10.001"},{"key":"3667_CR40","doi-asserted-by":"publisher","unstructured":"Walker EJ, Su H, Shen F (2012) Abstract 3194: Bevacizumab (Avastin) Crosses the Blood-brain Barrier and Attenuates VEGF-induced Angiogenesis and Vascular Dysplasia in an Adult Mouse Model of Brain Arteriovenous Malformations. Stroke 2012;43(suppl_1):A3194-A3194. https:\/\/doi.org\/10.1161\/str.43.suppl_1.A3194","DOI":"10.1161\/str.43.suppl_1.A3194"},{"key":"3667_CR41","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/ana.22348","volume":"69","author":"EJ Walker","year":"2011","unstructured":"Walker EJ, Su H, Shen F, Choi E-J, Oh SP, Chen G, Lawton MT, Kim H, Chen Y, Chen W, Young WL (2011) Arteriovenous malformation in the adult mouse brain resembling the human disease. Ann Neurol 69:954\u2013962. https:\/\/doi.org\/10.1002\/ana.22348","journal-title":"Ann Neurol"},{"key":"3667_CR42","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1161\/STROKEAHA.111.647982","volume":"43","author":"EJ Walker","year":"2012","unstructured":"Walker EJ, Su H, Shen F, Degos V, Amend G, Jun K, Young WL (2012) Bevacizumab attenuates VEGF-Induced angiogenesis and vascular malformations in the adult mouse brain. Stroke 43:1925\u20131930. https:\/\/doi.org\/10.1161\/STROKEAHA.111.647982","journal-title":"Stroke"},{"key":"3667_CR43","doi-asserted-by":"publisher","first-page":"972","DOI":"10.3171\/2012.1.JNS111627","volume":"116","author":"BJ Williams","year":"2012","unstructured":"Williams BJ, Park DM, Sheehan JP (2012) Bevacizumab used for the treatment of severe, refractory perilesional oedema due to an arteriovenous malformation treated with stereotactic radiosurgery. J Neurosurg May 116:972\u2013977. https:\/\/doi.org\/10.3171\/2012.1.JNS111627","journal-title":"J Neurosurg May"},{"key":"3667_CR44","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neuint.2019.03.002","volume":"126","author":"EA Winkler","year":"2019","unstructured":"Winkler EA, Lu AY, Raygor KP (2019) Defective vascular signaling & prospective therapeutic targets in brain arteriovenous malformations. Neurochem Int Jun 126:126\u2013138. https:\/\/doi.org\/10.1016\/j.neuint.2019.03.002","journal-title":"Neurochem Int Jun"},{"key":"3667_CR45","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1161\/STROKEAHA.117.020356","volume":"49","author":"W Zhu","year":"2018","unstructured":"Zhu W, Chen W, Zou D (2018) Thalidomide reduces hemorrhage of brain arteriovenous malformations in a mouse model. Stroke May 49:1232\u20131240. https:\/\/doi.org\/10.1161\/STROKEAHA.117.020356","journal-title":"Stroke May"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03667-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-025-03667-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03667-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T04:20:55Z","timestamp":1772079655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-025-03667-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3667"],"URL":"https:\/\/doi.org\/10.1007\/s10143-025-03667-y","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, no human participants as this is a systematic review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"506"}}